Search Results - "Bischof, G. N."

Introducing a gatekeeping system for amyloid status assessment in mild cognitive impairment by Doering, E., Hoenig, M. C., Bischof, G. N., Bohn, K. P., Ellingsen, L. M., van Eimeren, T., Drzezga, A.

“…Background In patients with mild cognitive impairment (MCI), enhanced cerebral amyloid-β plaque burden is a high-risk factor to develop dementia with…”
Get full text

The strategic biomarker roadmap for the validation of Alzheimer’s diagnostic biomarkers: methodological update by Boccardi, Marina, Dodich, Alessandra, Albanese, Emiliano, Gayet-Ageron, Angèle, Festari, Cristina, Ashton, Nicholas J., Bischof, Gérard N., Chiotis, Konstantinos, Leuzy, Antoine, Wolters, Emma E., Walter, Martin A., Rabinovici, Gil D., Carrillo, Maria, Drzezga, Alexander, Hansson, Oskar, Nordberg, Agneta, Ossenkoppele, Rik, Villemagne, Victor L., Winblad, Bengt, Frisoni, Giovanni B., Garibotto, Valentina

“…Background The 2017 Alzheimer’s disease (AD) Strategic Biomarker Roadmap (SBR) structured the validation of AD diagnostic biomarkers into 5 phases,…”
Get full text

Clinical validity of second-generation tau PET tracers as biomarkers for Alzheimer’s disease in the context of a structured 5-phase development framework by Bischof, Gérard N, Dodich, Alessandra, Boccardi, Marina, van Eimeren, Thilo, Festari, Cristina, Barthel, Henryk, Hansson, Oskar, Nordberg, Agneta, Ossenkoppele, Rik, Sabri, Osama, Giovanni, B Frisoni G, Garibotto, Valentina, Drzezga, Alexander

“…Purpose In 2017, the Geneva Alzheimer’s disease (AD) strategic biomarker roadmap initiative proposed a framework of the systematic validation AD biomarkers to…”
Get full text

Association Between Years of Education and Amyloid Burden in Patients With Subjective Cognitive Decline, MCI, and Alzheimer Disease by Hönig, Merle, Altomare, Daniele, Caprioglio, Camilla, Collij, Lyduine, Barkhof, Frederik, Van Berckel, Bart, Scheltens, Philip, Farrar, Gill, Battle, Mark R, Theis, Hendrik, Giehl, Kathrin, Bischof, Gerard N, Garibotto, Valentina, Molinuevo, José Luis L, Grau-Rivera, Oriol, Delrieu, Julien, Payoux, Pierre, Demonet, Jean Francois, Nordberg, Agneta K, Savitcheva, Irina, Walker, Zuzana, Edison, Paul, Stephens, Andrew W, Gismondi, Rossella, Jessen, Frank, Buckley, Christopher J, Gispert, Juan Domingo, Frisoni, Giovanni B, Drzezga, Alexander

“…Higher-educated patients with Alzheimer disease (AD) can harbor greater neuropathologic burden than those with less education despite similar symptom severity…”
Get full text

The Strategic Biomarker Roadmap for the validation of Alzheimer's diagnostic biomarkers: methodological update (vol 48, pg 2070, 2021) by Boccardi, M, Dodich, A, Albanese, E, Gayet-Ageron, A, Festari, C, Ashton, NJ, Bischof, GN, Chiotis, K, Leuzy, A, Wolters, EE

Get full text

Correction to: The Strategic Biomarker Roadmap for the validation of Alzheimer’s diagnostic biomarkers: methodological update by Boccardi, Marina, Dodich, Alessandra, Albanese, Emiliano, Gayet-Ageron, Angèle, Festari, Cristina, Ashton, Nicholas J., Bischof, Gérard N., Chiotis, Konstantinos, Leuzy, Antoine, Wolters, Emma E., Walter, Martin, Rabinovici, Gil D., Carrillo, Maria, Drzezga, Alexander, Hansson, Oskar, Nordberg, Agneta, Ossenkoppele, Rik, Villemagne, Victor L., Winblad, Bengt, Frisoni, Giovanni, Garibotto, Valentina

Get full text